TransMedics (TMDX) Change in Acquisitions & Divestments (2018 - 2022)

TransMedics' Change in Acquisitions & Divestments history runs 4 years deep, the most recent figure standing at $28.7 million for Q3 2022.

• On a quarterly basis, Change in Acquisitions & Divestments rose 4.24% year-over-year to $28.7 million in Q3 2022; TTM through Dec 2022 was $76.9 million, a 26.61% decrease from a year earlier, with the FY2022 full-year figure at $76.9 million, down 26.61% from the prior year.
• Change in Acquisitions & Divestments declined to $28.7 million in Q3 2022 per TMDX's latest filing, from $33.8 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $37.8 million in Q2 2021 and bottomed at $750000.0 in Q3 2018.
• The 4-year median for Change in Acquisitions & Divestments is $18.7 million (2020), against an average of $19.7 million.
• Biggest YoY gain for Change in Acquisitions & Divestments was 100.42% in 2021; the steepest drop was 38.67% in 2021.
• Year by year, Change in Acquisitions & Divestments stood at $750000.0 in 2018, then jumped by 3922.27% to $30.2 million in 2020, then tumbled by 38.67% to $18.5 million in 2021, then surged by 54.95% to $28.7 million in 2022.
• Per Business Quant, the three latest TMDX Change in Acquisitions & Divestments figures stand at $28.7 million (Q3 2022), $33.8 million (Q2 2022), and $14.5 million (Q1 2022).